EUVIMEDEUVIMED entdecken
Übersichtsarbeit

DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates the haematopoiesis

Sumit Mallick

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-12293-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Sumit Mallick. Beteiligte Einrichtung: Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte (Deemed to be University), Mangalore, 57…. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Proto-Oncogene Proteins, Hematopoiesis, DNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes (T1D) is an autoimmune disorder characterized by insulin deficiency and hyperglycemia, driven by environmental insults and epigenetic reprogramming beyond genetic predisposition. Recent evidence suggests that systemic epigenetic dysregulation in T1D influences the differentiation of hematopoietic stem cells (HSCs) towards pro-inflammatory myeloid subsets, such as macrophages and dendritic cells, and compromises lymphoid tolerance, including Treg dysfunction. Mechanistically, perturbations in mitochondrial metabolism in HSCs disrupt the α-ketoglutarate/succinate ratio, which directly regulates TET dioxygenases and DNMTs. Concurrently, dysregulated DNA methylation, histone marks (e.g., H3K27me3), and noncoding RNAs (e.g., MALAT1) connect genetic risk to environmental signals. Clonal hematopoiesis (CHIP), enhanced in T1D by mutations in TET2 and DNMT3A, fuels inflammation by proliferating cytokine-excess HSC clones, thereby accelerating β-cell death. This review provides a comprehensive overview of the current research updates of the disease, including the complex network-mediated epigenetically altered T1D. Moreover, I have explored how epigenetics is involved in hematopoietic dysfunction and how epigenetic reprogramming may underpin these pathologies to mitigate T1D complications and enhance patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticProto-Oncogene ProteinsHematopoiesisDNA-Binding ProteinsDiabetes Mellitus, Type 1DNA (Cytosine-5-)-MethyltransferasesHumansDioxygenasesAnimalsDNA Methyltransferase 3ADNA MethylationHematopoietic Stem CellsCell Differentiation

Stichwörter der Autor:innen

EpigeneticsHematopoiesisInflammationsObesityPTMsTranscription factorsType 1 diabetes

Substanzen

Proto-Oncogene ProteinsTET2 protein, humanDioxygenasesDNA-Binding ProteinsDNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesDNMT3A protein, human

Autor:innen und Institutionen

  • Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte (Deemed to be University), Mangalore, 575018, Karnataka, India. sumit95.zsi@gmail.com.
  • Cellular Biophysics Lab, Department of Bioscience and Bioengineering, Indian Institute of Technology Bombay, Powai, Maharashtra, 400076, India. sumit95.zsi@gmail.com.

Zitieren

APA

Mallick, S. (2026). DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates the haematopoiesis. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12293-w

Vancouver

Mallick S. DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates the haematopoiesis. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12293-w

BibTeX
@article{Mallick2026,
  author = {Mallick, Sumit},
  title = {DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates the haematopoiesis},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-12293-w}
}
Kostenlos starten →